Analyst stock forecast
Neurogene Forecast: $80.43 Analyst Target
NGNE has a $80.43 target, Strong Buy rating and 7 analysts. As of 2026-08-18.
Direct answer
Neurogene's average price target is $80.43.
The target implies +121.1% from the recorded current price, and the consensus rating is Strong Buy.
The low target implies +26.4%, the high target implies +356.3%, and the range spans 329.9% of the current price.
Forecast evidence checked August 18, 2026.
Get free Neurogene email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $36.38
- Average price target
- $80.43
- High price target
- $166.00
- Low price target
- $46.00
- Low target gap
- +26.4%
- Target upside
- +121.1%
- High target gap
- +356.3%
- Target range width
- 329.9%
- Consensus rating
- Strong Buy
- Analysts
- 7
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is Neurogene's average price target?
Neurogene's verified average price target is $80.43. The target range is $46.00 to $166.00.
How far are Neurogene's low and high targets from the recorded price?
The low target implies +26.4%, while the high target implies +356.3%.
How many analysts are included in Neurogene's consensus?
The verified consensus includes 7 analysts.
How is Neurogene's target upside or downside calculated?
The average target of $80.43 is divided by the recorded price of $36.38, then one is subtracted to produce +121.1%. This does not guarantee a future return.
When was Neurogene's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.